Original Source(s)
Could One Test Replace Multiple Leukemia Assays?
May 29, 2026
Related Content
Why We Made a Mobile Digital Pathology Lab
Todd R. Minnigh and his team created ScanVan to address a problem with rare cancer diagnosis that had a particularly personal significance
May 29, 2026
-
8 min
Preclinical Study in Mice Addresses a Question: Should RAS Inhibitors Be Given Preemptively?
With recent data that RAS inhibition can improve survival in metastatic pancreatic cancer, the optimization of these agents has become a research priority. Minh Than, MD, PhD, a clinical and research ...
May 28, 2026
-
4 min
FDA Approves Durvalumab Plus BCG for High-Risk NMIBC
On May 28, 2026, the U.S. Food and Drug Administration (FDA) approved the PD-L1 inhibitor durvalumab (Imfinzi) in combination with bacillus Calmette-Guérin (BCG) for the treatment of adult patients wi...
May 28, 2026
-
2 min
